Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Havn Life Sciences Inc
(CSE:
HAVN
)
0.0300
UNCHANGED
Last Price
Updated: 2:12 PM EST, Nov 9, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Havn Life Sciences Inc
The Power Play by The Market Herald Releases New Interviews with SuperBuzz, HAVN Life Sciences and RevoluGROUP Discussing Their Latest News
October 31, 2022
Via
ACCESSWIRE
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
April 30, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
HAVN Life Sciences Inc.
Via
AccessWire
HAVN Life Sciences (CSE: HAVN) (OTC: HAVLF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
April 14, 2022
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) Featured in Virtual Coverage of LD Micro’s Main Event
October 01, 2021
Via
Investor Brand Network
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will...
From
Stock News Now
Via
AccessWire
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
September 23, 2021
The partnership is a integral step in the The Company's path to market in the U.S., achieving one of its most important milestones to-date VANCOUVER, BC / ACCESSWIRE / September 23, 2021 / Havn Life...
From
Havn Life Sciences Inc.
Via
AccessWire
Exposures
Product Safety
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
September 21, 2021
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction of...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
August 25, 2021
The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company"...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
August 03, 2021
HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common Market to export psilocybin. VANCOUVER, BC /...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
HAVN Life Natural Health Products Now Available on Amazon.ca
July 29, 2021
With FBA designation, the Company continues to grow its retail footprint by partnering with the world's largest ecommerce site VANCOUVER, BC / ACCESSWIRE / July 29, 2021 / Havn Life Sciences Inc....
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
July 27, 2021
The Agreement with P.A. Benjamin Manufacturing Company whom operates a GMP compliant facility in Jamaica VANCOUVER, BC / ACCESSWIRE / July 27, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech
July 08, 2021
The Company will supply naturally-derived psilocybin for the development of psilocybin microdosing health products VANCOUVER, BC / ACCESSWIRE / July 8, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health
June 29, 2021
The Agreement will utilize HAVN Life's fully integrated supply chain model, from the growing of psilocybin through to extraction, compounding, and encapsulation VANCOUVER, BC / ACCESSWIRE / June 29,...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
HAVN Life Announces Retail Partnership with Grocer, Choices Markets
June 08, 2021
Newly-launched line of natural health products to be available at all locations later this month VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP)...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Launches New Line of Natural Health Products
June 03, 2021
Seven New Formulations That Support Brain Health and Immune Function Will Be Available Online and at Select Retail Locations Starting June 3 VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / HAVN Life...
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
June 02, 2021
The Company will seek Orphan Drug Designation to significantly reduce time to market VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings
May 19, 2021
Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the...
From
Havn Life Sciences Inc.
Via
AccessWire
The Miracle Compound Tackling A Trillion Dollar Crisis
May 17, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
May 17, 2021
HAVN Life works towards substantiating a patent application and preclinical work VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / HAVN Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company"...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
May 14, 2021
Havn Life will join 80+ other small cap and micro-cap companies at leading event for investors VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP)...
From
Havn Life Sciences Inc.
Via
AccessWire
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
May 13, 2021
Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC...
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
Havn Life Develops New Method for Rapid Psilocybin Testing
May 11, 2021
Havn Life has completed its analytical work under its Health Canada Section 56 exemption VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the...
From
Havn Life Sciences Inc.
Via
AccessWire
Havn Labs Jamaica Facility Now Fully Operational
May 04, 2021
The Company has started production of its first grow with local partner Hypha Wellness VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the...
From
Havn Life Sciences Inc.
Via
AccessWire
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027
April 14, 2021
Via
FinancialNewsMedia
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
April 19, 2021
LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be...
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
April 08, 2021
The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. VANCOUVER, BC / ACCESSWIRE / April 8, 2021 / Havn Life Sciences Inc....
From
Havn Life Sciences Inc.
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.